Report cover image

Global Cannabidiol Market Growth, Size, Trends Analysis- By Source Type, By Sales Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 08, 2025
Length 254 Pages
SKU # SPER20314907

Description

Cannabidiol Market Introduction and Overview

According to SPER market research, ‘Global Cannabidiol Market Size- By Component, By Industry – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Cannabidiol Market is predicted to reach 40.01 billion by 2034 with a CAGR 16.06%.

Cannabidiol, or CBD, is a natural compound derived from the cannabis plant. Unlike THC, its more famous counterpart, CBD is non-psychoactive and does not cause a “high.” In recent years, it has gained widespread attention for its potential health benefits, such as easing pain, reducing inflammation, alleviating anxiety, and controlling seizures. CBD works by interacting with the body’s endocannabinoid system, which plays a role in regulating mood, sleep, and immune function.

Restraints:The cannabidiol (CBD) oil market faces numerous challenges that could hinder its growth and progress. One of the biggest obstacles is regulatory uncertainty, as laws governing CBD products differ significantly across regions and can change quickly, causing confusion for both manufacturers and consumers. Issues with quality control and product consistency, including varying potency and potential contamination, also undermine consumer confidence.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Source Type, By Sales Type, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered ENDOCA, NuLeaf Naturals, LLC, Isodiol International, Inc., PharmaHemp, The Cronos Group, Cannoid, LLC, Medical Marijuana, Inc., Folium Europe B.V., Canopy Growth Corporation, Elixinol.

Global Cannabidiol Market Segmentation:

By Source Type: Based on the Source Type, Global Cannabidiol Market is segmented as; Hemp, Marijuana.

By Sales Type: Based on the Sales Type, Global Cannabidiol Market is segmented as; B2B, B2C, By Sales Channel, Hospital Pharmacies, Online, Retail Stores.

By End Use: Based on the End Use, Global Cannabidiol Market is segmented as; Medical, Personal Use, Pharmaceuticals, Wellness, Food & Beverages, Personal Care & Cosmetics, Nutraceuticals, Others

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

254 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Cannabidiol Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cannabidiol Market
7. Global Cannabidiol Market, By Source Type, (USD Million) 2021-2034
7.1. Hemp
7.2. Marijuana
8. Global Cannabidiol Market, By Sales Type, (USD Million) 2021-2034
8.1. B2B
8.2. B2C
8.3. By Sales Channel
8.4. Hospital Pharmacies
8.5. Online
8.6. Retail Stores
9. Global Cannabidiol Market, By End Use, (USD Million) 2021-2034
9.1. Medical
9.1.1. Chronic Pain
9.1.2. Mental Disorders
9.1.3. Cancer
9.1.4. Others
9.2. Personal Use
9.3. Pharmaceuticals
9.4. Wellness
9.5. Food & Beverages
9.6. Personal Care & Cosmetics
9.7. Nutraceuticals
9.8. Others
10. Global Cannabidiol Market, (USD Million) 2021-2034
10.1. Global Cannabidiol Market Size and Market Share
11. Global Cannabidiol Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. ENDOCA
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Cannoid, LLC
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Medical Marijuana, Inc.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Folium Europe B.V.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Canopy Growth Corporation
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Elixinol
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. NuLeaf Naturals, LLC
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Isodiol International, Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. PharmaHemp
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. The Cronos Group
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us